“…To best support BF parents, including those of vulnerable infants most in need of HM, clinicians should familiarize themselves with up‐to‐date guidance from the Centers for Disease Control and Prevention and the American Academy of Pediatrics on contraindications for providing maternal HM, 7,24,25 which may vary based on available resources and circumstances. For example, although maternal human immunodeficiency virus (HIV) infection has long been considered a contraindication to BF, the World Health Organization recommends antiretroviral therapy, which greatly reduces postnatal transmission of HIV through maternal HM, and supports BF as long as desired 26 . Additionally, few medications are fully incompatible with BF, and infant age and health status, lactational stage, dosage, and timing of medication may alter the risk profile for an individual infant; the InfantRisk Center at Texas Tech University Health Sciences Center (https://infantrisk.com/) provides individualized, up‐to‐date guidance.…”